Back to WELLS FARGO & COMPANY/MN WELLS FARGO & COMPANY/MN

ATXIATXI
7 quarters

Position history for WELLS FARGO & COMPANY/MNWELLS FARGO & COMPANY/MN's holdings in Avenue Therapeutics, Inc.

WELLS FARGO & COMPANY/MN previously held 0 shares of ATXI (Avenue Therapeutics, Inc.), worth $0 as of 2025-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$3,242

Total Shares Change

-4,585

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q1
Latest
Exited
0
-100.0%
$00.0%$0.31
0
2024-Q4
Decreased
500
-10.9%
$1,0000.0%$1.94
0
2024-Q3
Increased
561
+819.7%
$1,3970.0%$2.51
12
2024-Q2
Decreased
61
-98.7%
$2140.0%$3.50
0
2024-Q1
Increased
4,801
+3.8%
$7090.0%$11.06
8
2023-Q4
Increased
4,624
+0.8%
$7450.0%$12.07
8
2023-Q3
New
4,585
-
$3,2420.0%$53.03
21

Other major holders of ATXI: RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used